Fundraising Fox

re.Mind Capital

Venture capitaloperating company · company profile

London · Pre-Seed–Series A · 2 people tracked

Find your way into re.Mind Capital

4,075 people in our graph share verified history with the re.Mind Capital team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Max de Vere · together at McKinsey & Company (overlapped)
×6knows the team · via University of Oxford
×4knows the team · via McKinsey & Company
knows the team · via Imperial College London
Fox Verdict
Sign up to see your fit

Investment thesis

An early-stage venture capital firm focused exclusively on investing in mental health, brain health, and human flourishing companies.

Source: firm website, verified Aug 6, 2026.

Stage
Pre-Seed–Series A
HQ
London, GB
Instruments
Equity
Tracked investments
5

Team · 2 people

from public directories
Max de Vere· Investorin

What they invest in

from 4 of 5 portfolio companies

Biotech ×3Digital Health ×3Medical Devices ×3Deep Tech ×2Healthtech ×2Wellness & Fitness ×1

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path

By year:2024 · 22021 · 24 dated

Anna Healthannaautismcare.comNov 2024 · $9M

ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching.

Digital HealthHealthtechWellness & FitnessBoston, US

Aimun Malik(Executive Officer, Director, Promoter)

BoardBinoy Bhansali(Director)Sean Doolan(Director)in

Co-investorsGreyMatterVirtue Ventures

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+6 more

Ksana Healthksanahealth.comin

Active seed-stage healthcare company

Eugene, US

Nicholas Allen(Chief Executive Officer)Phillip Scripa(Chief Financial Officer and Secretary)William Shortt(Chief Operating Officer)Jan Hardorp(Director)

Co-investorsBIP VenturesJLS

Motif Neurotechmotifneuro.techin𝕏Jan 2024 · $19M

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)

BoardJacob Robinson(Co-founder & CEO)in

Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundXEIA Venture PartnersCapital FactoryDivergent Capital+3 more

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)inThomas Oxley(Founder)in

BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)

Co-investorsARCH Venture PartnersForepont Capital PartnersID8 InvestmentsKaleida CapitalKhosla VenturesBezos Expeditions+4 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does re.Mind Capital invest at?
re.Mind Capital invests at the Pre-Seed, Seed, Series A stages.
What sectors does re.Mind Capital focus on?
re.Mind Capital focuses on Healthtech, Mental Health, Wellness & Fitness.
Where is re.Mind Capital located?
re.Mind Capital is headquartered in London, GB.

Co-investors · 3

Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

$500K – $5M
What If Ventures

What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

Firms observed investing alongside re.Mind Capital, from public investor directories. Shared companies are the overlap with re.Mind Capital's recorded portfolio.

Similar investors

Featured in lists